Skip to content

Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01823484
Enrollment
40
Registered
2013-04-04
Start date
2012-01-31
Completion date
Unknown
Last updated
2014-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Critically Ill, Septic Shock

Keywords

hemofilter, coagulation, CRRT, critically ill

Brief summary

Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and decrease the quantity of heparin during continuous renal replacement therapy in critically ill.

Interventions

DEVICEAN 69 ST hemofilter
DEVICEAN 69 hemofilter

Sponsors

Zhongda Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* age\> 18 years old * admitted to ICU and need CRRT * anticipated survival time \>72h

Exclusion criteria

* allergy to hemofilter or heparin * heparin associated thrombocytopenia * pregnancy or lactation * using other anticoagulate drugs

Design outcomes

Primary

MeasureTime frameDescription
The using time of hemofilters72hThe time from the beginning of continuous renal replacement therapy until to the end when continuous renal replacement therapy had to be finished because of clotting or other reasons

Secondary

MeasureTime frameDescription
activated partial thromboplastin timeevery 6h from the begining of continuous renal replacement therapy,up to 72hHeparin will be used according to activated partial thromboplastin time, and the quantity will be recorded.

Other

MeasureTime frame
Number of participants with adverse events during continuous renal replacement therapy72h

Countries

China

Contacts

Primary ContactQiu Xiaohua
xiaohua0917@163.com02583262553

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026